JP2023519518A5 - - Google Patents
Info
- Publication number
- JP2023519518A5 JP2023519518A5 JP2022554199A JP2022554199A JP2023519518A5 JP 2023519518 A5 JP2023519518 A5 JP 2023519518A5 JP 2022554199 A JP2022554199 A JP 2022554199A JP 2022554199 A JP2022554199 A JP 2022554199A JP 2023519518 A5 JP2023519518 A5 JP 2023519518A5
- Authority
- JP
- Japan
- Prior art keywords
- antisense oligomer
- ace2
- composition according
- composition
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900883A AU2020900883A0 (en) | 2020-03-23 | Antisense Oligomers for Treatment of Disease | |
| AU2020900883 | 2020-03-23 | ||
| PCT/AU2021/050261 WO2021189104A1 (en) | 2020-03-23 | 2021-03-22 | Antisense oligomers for treatment of disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023519518A JP2023519518A (ja) | 2023-05-11 |
| JP2023519518A5 true JP2023519518A5 (https=) | 2024-03-12 |
Family
ID=77889846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554199A Pending JP2023519518A (ja) | 2020-03-23 | 2021-03-22 | 疾患の処置のためのアンチセンスオリゴマー |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230407309A1 (https=) |
| EP (1) | EP4127174A4 (https=) |
| JP (1) | JP2023519518A (https=) |
| CN (1) | CN115397988A (https=) |
| AU (1) | AU2021244774A1 (https=) |
| WO (1) | WO2021189104A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115916976A (zh) * | 2020-07-28 | 2023-04-04 | 神户天然物化学株式会社 | 诱导血管紧张素转换酶2基因外显子跳跃的反义核酸 |
| TW202229554A (zh) * | 2020-12-31 | 2022-08-01 | 中山大學附屬第一醫院 | 用於降低血管收縮素轉化酶２（ａｃｅ２）之表現的寡核苷酸及其用於治療病毒感染的用途 |
| KR20250005287A (ko) * | 2022-04-14 | 2025-01-09 | 쉬프트 파마수티컬스 홀딩 인크. | 샤르코-마리-투스병에 대한 폴리뉴클레오타이드 치료 |
| CA3256035A1 (en) * | 2022-04-14 | 2023-10-19 | Invisishield Technologies Ltd. | COMPOSITIONS FOR PREVENTING OR TREATMENT OF CORONAVIRUS INFECTIONS |
| WO2023201306A1 (en) | 2022-04-14 | 2023-10-19 | Invisishield Technologies Ltd. | Compositions for preventing or treating influenza infections |
| WO2024233583A2 (en) * | 2023-05-08 | 2024-11-14 | Carisma Therapeutics Inc. | Compositions and methods relating to intronic shrna chimeric antigen receptor constructs |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610497B1 (en) * | 1997-12-11 | 2003-08-26 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| US6989363B1 (en) * | 1997-12-11 | 2006-01-24 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| US20050203038A1 (en) * | 2004-03-10 | 2005-09-15 | Isis Pharmaceuticals Inc. | Modulation of ACE2 expression |
| US20070185044A1 (en) * | 2005-03-08 | 2007-08-09 | Dobie Kenneth W | Modulation of ace2 expression |
| EP1857548A1 (en) * | 2006-05-19 | 2007-11-21 | Academisch Ziekenhuis Leiden | Means and method for inducing exon-skipping |
| CN111979273B (zh) * | 2020-08-24 | 2022-05-27 | 苏州启辰生物科技有限公司 | 一种制备人源化ace2小鼠模型的方法 |
-
2021
- 2021-03-22 AU AU2021244774A patent/AU2021244774A1/en active Pending
- 2021-03-22 CN CN202180023548.6A patent/CN115397988A/zh active Pending
- 2021-03-22 JP JP2022554199A patent/JP2023519518A/ja active Pending
- 2021-03-22 EP EP21776876.1A patent/EP4127174A4/en not_active Withdrawn
- 2021-03-22 US US17/909,947 patent/US20230407309A1/en active Pending
- 2021-03-22 WO PCT/AU2021/050261 patent/WO2021189104A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023519518A5 (https=) | ||
| JP7442574B2 (ja) | Ｌｐａの遺伝子発現の阻害のための組成物及び方法 | |
| EP3896451B1 (en) | Carm1 inhibitors for facioscapulohumeral muscular dystrophy | |
| DK2850186T3 (en) | COMPOSITIONS AND PROCEDURES FOR MODULATING SMN GENFAMILY EXPRESSION | |
| DK2850189T3 (en) | COMPOSITIONS AND PROCEDURES FOR MODULATING GENEPRESSION | |
| KR970005274B1 (ko) | 안티센스 올리고뉴클레오티드에 의한 a형 인플루엔자 바이러스, 안 아아보스트레인(ann arbor strain) h2n2의 억제 | |
| US20180312839A1 (en) | Methods and compositions for increasing smn expression | |
| TW201920227A (zh) | 用於抑制脂蛋白元C-III (APOC3)表現之RNAi試劑及組合物 | |
| JP2019531763A5 (https=) | ||
| US20240000824A1 (en) | Oligonucleotides containing 2'-deoxy-2'fluoro-beta-d-arabinose nucleic acid (2'-fana) for treatment and diagnosis of retroviral diseases | |
| EP3573618B1 (en) | Compositions and methods for hemoglobin production | |
| JP7842395B2 (ja) | エクソンスキッピングを可能にするアンチセンス核酸 | |
| CN113930422B (zh) | 人igfl3基因的用途及相关产品 | |
| WO2022026648A1 (en) | Inhibition of incexact1 to treat heart disease | |
| JP2026502888A (ja) | エピジェネティック調節因子の新規阻害剤 | |
| US20190055553A1 (en) | Methods for identifying and targeting non-coding rna scaffolds | |
| WO2019178187A1 (en) | Compositions and methods for hemoglobin production | |
| CA3207426A1 (en) | Epigenetic silencing for treatment of cancer | |
| US20230265426A1 (en) | Combinatorial inhibition of mirnas for treatment of heart failure | |
| CN113917146B (zh) | 人pole2基因的用途及相关产品 | |
| US20250129368A1 (en) | siRNA based on RNA sequence of SARS-CoV-2 and use thereof | |
| KR100741374B1 (ko) | 동물에서 아데노바이러스의 증식을 억제하는 방법 | |
| JP2024501762A (ja) | アンジオテンシン変換酵素２（ａｃｅ２）の発現を低減させるためのオリゴヌクレオチド、及びウイルス感染を処置するためのその使用 | |
| CN101503437B (zh) | 核酸分子si-cypj-4及其在制备抗癌药物中的应用 | |
| CN117562913A (zh) | 连翘活性成分组合在制备拮抗SARS-CoV-2突变毒株的药物中的应用 |